PlainPharmaWatch

CMS Open Payments · Tool

Asahi Intecc USA, Inc. vs Virtual Incision Corporation

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Virtual Incision Corporation has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 1,423, versus 885 for the other company. Its single largest recorded recipient represents 31.4% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Asahi Intecc USA, Inc.
HHI 885 · top recipient 22.6%
Ranked #1,074 of 1,838 companies by HHI
Virtual Incision Corporation
HHI 1,423 · top recipient 31.4%
Ranked #890 of 1,838 companies by HHI

Payment Overview

Total Payments
$443.1K
% of Industry
0.0%
Transactions
1,313
Avg per Transaction
$337.45
Recipients
1,313
Avg per Recipient
$337.45
Payment Types
5
Top Payment Type
Grant
Total Payments
$447.4K
% of Industry
0.0%
Transactions
683
Avg per Transaction
$655.10
Recipients
683
Avg per Recipient
$655.10
Payment Types
3
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Asahi Intecc USA, Inc. vs Virtual Incision Corporation - total reported payments in CMS Open Payments PY2024

Virtual Incision Corporation$447.4KAsahi Intecc USA, Inc.$443.1K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Asahi Intecc USA, Inc.

Grant $225.0K

50.8%

Honoraria $138.2K

31.2%

Food and Beverage $70.5K

15.9%

Travel and Lodging $8.0K

1.8%

Consulting Fee $1.4K

0.3%

Virtual Incision Corporation

Consulting Fee $361.5K

80.8%

Travel and Lodging $58.3K

13.0%

Food and Beverage $27.7K

6.2%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Asahi Intecc USA, Inc.

  1. 1

    University Of Chicago Hospitals

    $100,000.00 · 1 txns

  2. 2

    University Of Washington Med Ctr

    $60,000.00 · 2 txns

  3. 3

    Massachusetts General Hospital

    $40,000.00 · 3 txns

  4. 4

    Emory University Hospital

    $25,000.00 · 1 txns

  5. 5

    AMEER HASSAN

    $19,411.05 · 6 txns

Virtual Incision Corporation

  1. 1

    DMITRY OLEYNIKOV

    $140,684.00 · 168 txns

  2. 2

    MICHAEL JOBST

    $79,693.00 · 61 txns

  3. 3

    GREGORY HEIDRICK

    $24,103.00 · 12 txns

  4. 4

    NADIA GOMEZ

    $19,758.00 · 10 txns

  5. 5

    MARTIN MARTINO

    $16,206.00 · 7 txns

Summary Comparison

Metric Asahi Intecc USA, Inc. Virtual Incision Corporation
Total Payments $443.1K $447.4K
% of Industry Total 0.0% 0.0%
Transaction Count 1,313 683
Avg per Transaction $337.45 $655.10
Recipient Count 1,313 683
Avg per Recipient $337.45 $655.10
Payment Type Count 5 3
Top Payment Type Grant Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.